CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry

References

• Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Cui G, Ren X, et al. A novel four-gene signature associated with immune checkpoint for predicting prognosis in lower-grade glioma. Front Oncol. 2020;10:605737.
   PubMed Web of Science ®Google Scholar
• Liu X, Li Y, Li S, et al. mutation-specific radiomic signature in lower-grade gliomas. Aging (Albany NY). 2019;11(2):673–696.
   PubMedGoogle Scholar
• Brat DJ, Verhaak RGW, Aldape KD, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372(26):2481–2498.
   PubMed Web of Science ®Google Scholar
• Martinsson-Ahlzén H-S, Liberal V, Grünenfelder B, et al. Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells. Mol Cell Biol. 2008;28(18):5698–5709.
   PubMed Web of Science ®Google Scholar
• Spruck CH, De Miguel MP, Smith APL, et al. Requirement of Cks2 for the first metaphase/anaphase transition of mammalian meiosis. Science. 2003;300(5619):647–650.
   PubMed Web of Science ®Google Scholar
• Zhang J, Song Q, Liu J, et al. Cyclin-dependent kinase regulatory subunit 2 indicated poor prognosis and facilitated aggressive phenotype of hepatocellular carcinoma. Dis Markers. 2019;2019:8964015.
   PubMed Web of Science ®Google Scholar
• Ji X, Xue Y, Wu Y, et al. High-expressed CKS2 is associated with hepatocellular carcinoma cell proliferation through down-regulating PTEN. Pathol Res Pract. 2018;214(3):436–441.
   PubMed Web of Science ®Google Scholar
• Shen D-Y, Fang Z-X, You P, et al. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. Liver Int. 2010;30(1):119–125.
   PubMed Web of Science ®Google Scholar
• Yang K, Gao J, Luo M. Identification of key pathways and hub genes in basal-like breast cancer using bioinformatics analysis. Onco Targets Ther. 2019;12:1319–1331.
   PubMed Web of Science ®Google Scholar
• Huang N, Wu Z, Hong H, et al. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer. Mol Med Rep. 2019;19(6):4761–4769.
   PubMed Web of Science ®Google Scholar
• Shen D-Y, Zhan Y-H, Wang Q-M, et al. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma. Liver Int. 2013;33(1):137–148.
   PubMed Web of Science ®Google Scholar
• Scrideli CA, Carlotti CG, Okamoto OK, et al. Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR. J Neurooncol. 2008;88(3):281–291.
   PubMed Web of Science ®Google Scholar
• Rickman DS, Bobek MP, Misek DE, et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 2001;61(18):6885–6891.
   PubMed Web of Science ®Google Scholar
• Cline MS, Craft B, Swatloski T, et al. Exploring TCGA pan-cancer data at the UCSC cancer genomics browser. Sci Rep. 2013;3:2652.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Meng F, Wang W, et al. Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas. Sci Data. 2017;4:170024.
   PubMed Web of Science ®Google Scholar
• Bao Z-S, Chen H-M, Yang M-Y, et al. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res. 2014;24(11):1765–1773.
   PubMed Web of Science ®Google Scholar
• Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–W60.
   PubMed Web of Science ®Google Scholar
• Sun L, Hui A-M, Su Q, et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 2006;9(4):287–300.
   PubMed Web of Science ®Google Scholar
• Gravendeel LAM, Kouwenhoven MCM, Gevaert O, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res. 2009;69(23):9065–9072.
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.
   PubMed Web of Science ®Google Scholar
• Fromowitz FB, Viola MV, Chao S, et al. ras p21 expression in the progression of breast cancer. Hum Pathol. 1987;18(12):1268–1275.
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W14.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• Chen S, Wei Y, Liu H, et al. Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics. Bioengineered. 2021;12(1):127–137.
   PubMed Web of Science ®Google Scholar
• Brzeziańska E, Dutkowska A, Antczak A. The significance of epigenetic alterations in lung carcinogenesis. Mol Biol Rep. 2013;40(1):309–325.
   PubMed Web of Science ®Google Scholar
• Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics. 2009;1(2):239–259.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang M, Tian N, et al. The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13. J Clin Invest. 2019;129(8):3072–3085.
   PubMed Web of Science ®Google Scholar
• Franceschi E, Tosoni A, Bartolini S, et al. Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas. Eur J Cancer. 2020;137:10–17.
   PubMed Web of Science ®Google Scholar
• Chen R, Feng C, Xu Y. Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression. J Int Med Res. 2011;39(2):533–540.
   PubMed Web of Science ®Google Scholar
• Kita Y, Nishizono Y, Okumura H, et al. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma. Oncol Rep. 2014;31(5):1986–1992.
   PubMed Web of Science ®Google Scholar
• Tanaka F, Matsuzaki S, Mimori K, et al. Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer. Int J Oncol. 2011;39(2):361–372.
   PubMed Web of Science ®Google Scholar
• Xu JH, Wang Y, Xu D. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer. Eur Rev Med Pharmacol Sci. 2019;23(8):3225–3234.
   PubMed Web of Science ®Google Scholar
• Jung Y, Lee S, Choi H-S, et al. Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data. Clin Cancer Res. 2011;17(4):700–709.
   PubMed Web of Science ®Google Scholar
• Lan Y, Zhang Y, Wang J, et al. Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer. 2008;123(3):543–551.
   PubMed Web of Science ®Google Scholar
• Li H-N, Zheng W-H, Du -Y-Y, et al. ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: an integrated bioinformatics analysis. Oncol Lett. 2020;19(3):2163–2174.
   PubMed Web of Science ®Google Scholar
• Gong Y, Liu Y, Wang T, et al. Age-associated proteomic signatures and potential clinically actionable targets of colorectal cancer. Mol Cell Proteomics. 2021;20:100115.
   PubMed Web of Science ®Google Scholar
• He L, Zhou H, Zeng Z, et al. Wnt/β-catenin signaling cascade: a promising target for glioma therapy. J Cell Physiol. 2019;234(3):2217–2228.
   PubMed Web of Science ®Google Scholar
• Pachow D, Wick W, Gutmann DH, et al. The mTOR signaling pathway as a treatment target for intracranial neoplasms. Neuro Oncol. 2015;17(2):189–199.
   PubMed Web of Science ®Google Scholar
• Guo H, Kang H, Tong H, et al. Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes. Eur Radiol. 2019;29(4):1893–1902.
   PubMed Web of Science ®Google Scholar
• Ludwig K, Kornblum HI. Molecular markers in glioma. J Neurooncol. 2017;134(3):505–512.
   PubMed Web of Science ®Google Scholar